TickerFactsScreenerDevelopers

Vistagen Therapeutics, Inc. (VTGN) — Total Assets

Annual figures by fiscal year, from SEC filings.

2011: $323.6K2012: $341.6K2013: $881.5K2014: $263.7K2015: $269.7K2016: $989.8K2017: $3.71M2018: $11.28M2019: $14.01M2020: $5.77M2021: $108.28M2022: $74.64M2023: $21.09M2024: $123.65M2025: $84.34M2026: $48.56M$48.56M
2011Total Assets (USD)2026
Fiscal YearTotal AssetsChange YoY
2026$48.56M-42.4%
2025$84.34M-31.8%
2024$123.65M+486.3%
2023$21.09M-71.7%
2022$74.64M-31.1%
2021$108.28M+1775.9%
2020$5.77M-58.8%
2019$14.01M+24.2%
2018$11.28M+203.8%
2017$3.71M+275.0%
2016$989.8K+267.0%
2015$269.7K+2.3%
2014$263.7K-70.1%
2013$881.5K+158.1%
2012$341.6K+5.6%
2011$323.6K—